The human-like robot that Tesla is developing is considered the “most important product” in 2021 that they are working on, CEO Elon Musk said during a fourth-quarter earnings call on Wednesday, CNBC
Ramping up production capacities and meeting supply demands of new COVID-19 vaccines and therapeutics is likely to be the key focus for pharma companies in 2022.
Ramping up production capacities and meeting supply demands of new COVID-19 vaccines and therapeutics is likely to be the key focus for pharma companies in 2022.
WITH 2022 on the horizon, Regnald D Hunter is not necessarily looking towards the future with hope, more with a sense of caution bred from hard lessons learned.